Depatuxizumab mafodotin Completed Phase 1 Trials for Burkitt Lymphoma / Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01786096A Safety Study of SGN-CD19A for Leukemia and Lymphoma